Abstract
Purpose of reviewDisease-modifying antirheumatic drugs (DMARDs) have dramatically improved patient outcomes in juvenile idiopathic arthritis (JIA). Ho......
小提示:本篇文献需要登录阅读全文,点击跳转登录